Show results for
Refine by
Non Muscle Invasive Bladder Cancer Nmibc Equipment & Supplies In In Europe
6 equipment items found
Manufactured by:OncoDiag based inMiserey, FRANCE
An accurate urine-based test for the surveillance of patients with low-, intermediate- and high-risk non-muscle-invasive bladder cancer ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 to 2 million in Europe, who undergo local resection of the tumor and then have 1-4 follow-up visits each year due to the high recurrence rate of the ...
by:Theralase Technologies Inc. based inToronto, ONTARIO (CANADA)
Theralase is laser focused on advancing the cutting-edge Anti-Cancer Therapy (“ACT”) towards commercialization, providing an alternative treatment methodology for Non-Muscle Invasive Bladder Cancer (“NMIBC”) patients globally. Theralase is dedicated to ...
Manufactured by:InnoMedicus based inCham, SWITZERLAND
The Combat BRS System is an innovative bladder recirculation system designed to deliver. Combat BRS is an innovative bladder recirculation system for the treatment of non muscle invasive bladder carcinomas (NMIBC) with thermotherapy and cytostatic agents such as Mitomycin C, Epirubicin, etc. The patented system allows an effective heat exchange with a constant temperature of 43 ±0.5 ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Avelumab (anti-PD-L1) is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated ...